CytoMed Therapeutics Ltd (GDTC)
2.13
-0.12
(-5.54%)
USD |
NASDAQ |
May 16, 16:00
2.18
+0.05
(+2.35%)
After-Hours: 20:00
CytoMed Therapeutics Total Liabilities (Quarterly): 0.8515M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.8515M |
| June 30, 2023 | 0.5501M |
| June 30, 2023 | 0.5501M |
| December 31, 2022 | 3.460M |
| Date | Value |
|---|---|
| June 30, 2022 | 2.580M |
| June 30, 2022 | 2.580M |
| December 31, 2021 | 2.582M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
0.5501M
Minimum
Jun 2023
3.460M
Maximum
Dec 2022
1.879M
Average
2.580M
Median
Jun 2022
Total Liabilities (Quarterly) Benchmarks
| Haw Par Corp Ltd | 88.72M |
| WAVE Life Sciences Ltd | 209.88M |
| ASLAN Pharmaceuticals Ltd | 38.95M |
| EUDA Health Holdings Ltd | 8.054M |
| Mobile-health Network Solutions | 3.810M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 9.365M |
| Shareholders Equity (Quarterly) | 8.514M |